Shanghai Fudan-Zhangjiang Bio-Phaπ≠rmaceutical Co., Ltd.σ© (hereinafter referred to as "F™₹≥ udan-Zhangjiang") and Shangh∏♠↑ai WD Pharmaceutical Co.Ω , Ltd. (hereinafter referΩ​ red to as "WD Pharma"₩₹& ;) signed the "Capital §αFunding Increase Agreemen ∞±t" and "the Share Transfer <→↑Agreement" on March 25, 2021. U‍&pon completion of th​σ'∞is transaction, the Company will holφ→d 39.57% of the equity of WD Ph±γ£$arm.